A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab As Monotherapy or Combined With Standard of Care Therapies in Adult Participants in China With B-Cell Non-Hodgkin Lymphoma
Condition:   B-Cell Non-Hodgkin Lymphoma Interventions:   Drug: Epcoritamab;   Drug: Cyclophosphamide;   Drug: Rituximab;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Prednisone;   Drug: Lenalidomide Sponsors:   AbbVie;   Genmab Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 21, 2022 Category: Research Source Type: clinical trials

Fitness Assessment in Young Adults Recovered From Lymphoma
Conditions:   Young Adults;   Lymphoma, Non-Hodgkin;   Hodgkin Disease Intervention:   Other: Indirect calorimetric test during submaximal exercise Sponsor:   University Hospital, Clermont-Ferrand Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2022 Category: Research Source Type: clinical trials